-
1
-
-
67349139181
-
Wnt pathway aberrations including autocrine Wnt activation occur at high frequency in human non-small-cell lung carcinoma
-
Akiri, G., et al. 2009. Wnt pathway aberrations including autocrine Wnt activation occur at high frequency in human non-small-cell lung carcinoma. Oncogene 28:2163-2172.
-
(2009)
Oncogene
, vol.28
, pp. 2163-2172
-
-
Akiri, G.1
-
2
-
-
33646587981
-
Furin-, ADAM 10-, and gamma-secretase-mediated cleavage of a receptor tyrosine phosphatase and regulation of beta-catenin's transcriptional activity
-
Anders, L., et al. 2006. Furin-, ADAM 10-, and gamma-secretase-mediated cleavage of a receptor tyrosine phosphatase and regulation of beta-catenin's transcriptional activity. Mol. Cell. Biol. 26:3917-3934.
-
(2006)
Mol. Cell. Biol.
, vol.26
, pp. 3917-3934
-
-
Anders, L.1
-
3
-
-
33645070536
-
The lysyl oxidase LOX is absent in basal and squamous cell carcinomas and its knockdown induces an invading phenotype in a skin equivalent model
-
Bouez, C., et al. 2006. The lysyl oxidase LOX is absent in basal and squamous cell carcinomas and its knockdown induces an invading phenotype in a skin equivalent model. Clin. Cancer Res. 12:1463-1469.
-
(2006)
Clin. Cancer Res.
, vol.12
, pp. 1463-1469
-
-
Bouez, C.1
-
4
-
-
53349162212
-
Jade-1 inhibits Wnt signalling by ubiquitylating beta-catenin and mediates Wnt pathway inhibition by pVHL
-
Chitalia, V. C., et al. 2008. Jade-1 inhibits Wnt signalling by ubiquitylating beta-catenin and mediates Wnt pathway inhibition by pVHL. Nat. Cell Biol. 10:1208-1216.
-
(2008)
Nat. Cell Biol.
, vol.10
, pp. 1208-1216
-
-
Chitalia, V.C.1
-
5
-
-
0025073054
-
Expression of gene rrg is associated with reversion of NIH 3T3 transformed by LTR-c-H-ras
-
Contente, S., K. Kenyon, D. Rimoldi, and R. M. Friedman. 1990. Expression of gene rrg is associated with reversion of NIH 3T3 transformed by LTR-c-H-ras. Science 249:796-798.
-
(1990)
Science
, vol.249
, pp. 796-798
-
-
Contente, S.1
Kenyon, K.2
Rimoldi, D.3
Friedman, R.M.4
-
6
-
-
0032984911
-
Epigenetic inhibition of lysyl oxidase transcription after transformation by ras oncogene
-
Contente, S., K. Kenyon, P. Sriraman, S. Subramanyan, and R. M. Friedman. 1999. Epigenetic inhibition of lysyl oxidase transcription after transformation by ras oncogene. Mol. Cell. Biochem. 194:79-91.
-
(1999)
Mol. Cell. Biochem.
, vol.194
, pp. 79-91
-
-
Contente, S.1
Kenyon, K.2
Sriraman, P.3
Subramanyan, S.4
Friedman, R.M.5
-
7
-
-
33744464528
-
The crystal structure of human receptor protein tyrosine phosphatase kappa phosphatase domain 1
-
Eswaran, J., J. E. Debreczeni, E. Longman, A. J. Barr, and S. Knapp. 2006. The crystal structure of human receptor protein tyrosine phosphatase kappa phosphatase domain 1. Protein Sci. 15:1500-1505.
-
(2006)
Protein Sci
, vol.15
, pp. 1500-1505
-
-
Eswaran, J.1
Debreczeni, J.E.2
Longman, E.3
Barr, A.J.4
Knapp, S.5
-
8
-
-
21644448430
-
Cellular fibronectin binds to lysyl oxidase with high affinity and is critical for its proteolytic activation
-
Fogelgren, B., et al. 2005. Cellular fibronectin binds to lysyl oxidase with high affinity and is critical for its proteolytic activation. J. Biol. Chem. 280:24690-24697.
-
(2005)
J. Biol. Chem.
, vol.280
, pp. 24690-24697
-
-
Fogelgren, B.1
-
9
-
-
0030012613
-
Association of human protein-tyrosine phosphatase kappa with members of the armadillo family
-
Fuchs, M., T. Muller, M. M. Lerch, and A. Ullrich. 1996. Association of human protein-tyrosine phosphatase kappa with members of the armadillo family. J. Biol. Chem. 271:16712-16719.
-
(1996)
J. Biol. Chem.
, vol.271
, pp. 16712-16719
-
-
Fuchs, M.1
Muller, T.2
Lerch, M.M.3
Ullrich, A.4
-
10
-
-
35648949978
-
Beta-catenin signaling in biological control and cancer
-
Gavert, N., and A. Ben-Ze'ev. 2007. Beta-catenin signaling in biological control and cancer. J. Cell. Biochem. 102:820-828.
-
(2007)
J. Cell. Biochem.
, vol.102
, pp. 820-828
-
-
Gavert, N.1
Ben-Zeev, A.2
-
11
-
-
0029156461
-
Cell surface expression of receptor protein tyrosine phosphatase RPTP mu is regulated by cell-cell contact
-
Gebbink, M. F., et al. 1995. Cell surface expression of receptor protein tyrosine phosphatase RPTP mu is regulated by cell-cell contact. J. Cell Biol. 131:251-260.
-
(1995)
J. Cell Biol.
, vol.131
, pp. 251-260
-
-
Gebbink, M.F.1
-
12
-
-
0034680779
-
Lysyl oxidase activates the transcription activity of human collagen III promoter
-
Giampuzzi, M., et al. 2000. Lysyl oxidase activates the transcription activity of human collagen III promoter. Possible involvement of Ku antigen. J. Biol. Chem. 275:36341-36349.
-
(2000)
Possible involvement of Ku antigen. J. Biol. Chem.
, vol.275
, pp. 36341-36349
-
-
Giampuzzi, M.1
-
13
-
-
77952316612
-
De novo synthesis of {beta}-catenin via H-Ras and MEK regulates airway smooth muscle growth
-
Gosens, R., et al. 2010. De novo synthesis of {beta}-catenin via H-Ras and MEK regulates airway smooth muscle growth. FASEB J. 24:757-768.
-
(2010)
FASEB J
, vol.24
, pp. 757-768
-
-
Gosens, R.1
-
14
-
-
45749115401
-
Inter-cellular adhesion disruption and the RAS/RAF and beta-catenin signalling in lung cancer progression
-
Gotz, R. 2008. Inter-cellular adhesion disruption and the RAS/RAF and beta-catenin signalling in lung cancer progression. Cancer Cell Int. 8:7.
-
(2008)
Cancer Cell Int
, vol.8
, pp. 7
-
-
Gotz, R.1
-
16
-
-
0027488135
-
Up-regulation of lysyl oxidase in spontaneous revertants of H-ras-transformed rat fibroblasts
-
Hajnal, A., R. Klemenz, and R. Schafer. 1993. Up-regulation of lysyl oxidase in spontaneous revertants of H-ras-transformed rat fibroblasts. Cancer Res. 53:4670-4675.
-
(1993)
Cancer Res
, vol.53
, pp. 4670-4675
-
-
Hajnal, A.1
Klemenz, R.2
Schafer, R.3
-
17
-
-
0029121634
-
Quantitative PCR of lysyl oxidase mRNA in malignantly transformed human cell lines demonstrates that their low lysyl oxidase activity is due to low quantities of its mRNA and low levels of transcription of the respective gene
-
Hamalainen, E. R., et al. 1995. Quantitative PCR of lysyl oxidase mRNA in malignantly transformed human cell lines demonstrates that their low lysyl oxidase activity is due to low quantities of its mRNA and low levels of transcription of the respective gene. J. Biol. Chem. 270:21590-21593.
-
(1995)
J. Biol. Chem.
, vol.270
, pp. 21590-21593
-
-
Hamalainen, E.R.1
-
18
-
-
0032483439
-
Identification of c-MYC as a target of the APC pathway
-
He, T. C., et al. 1998. Identification of c-MYC as a target of the APC pathway. Science 281:1509-1512.
-
(1998)
Science
, vol.281
, pp. 1509-1512
-
-
He, T.C.1
-
19
-
-
0037377720
-
Lysyl oxidase inhibits ras-mediated transformation by preventing activation of NF-kappa B
-
Jeay, S., S. Pianetti, H. M. Kagan, and G. E. Sonenshein. 2003. Lysyl oxidase inhibits ras-mediated transformation by preventing activation of NF-kappa B. Mol. Cell. Biol. 23:2251-2263.
-
(2003)
Mol. Cell. Biol.
, vol.23
, pp. 2251-2263
-
-
Jeay, S.1
Pianetti, S.2
Kagan, H.M.3
Sonenshein, G.E.4
-
20
-
-
0027312030
-
Cloning and characterization of R-PTP-kappa, a new member of the receptor protein tyrosine phosphatase family with a proteolytically cleaved cellular adhesion molecule-like extracellular region
-
Jiang, Y. P., et al. 1993. Cloning and characterization of R-PTP-kappa, a new member of the receptor protein tyrosine phosphatase family with a proteolytically cleaved cellular adhesion molecule-like extracellular region. Mol. Cell. Biol. 13:2942-2951.
-
(1993)
Mol. Cell. Biol.
, vol.13
, pp. 2942-2951
-
-
Jiang, Y.P.1
-
21
-
-
4644256597
-
Lysyl oxidase is a tumor suppressor gene inactivated by methylation and loss of heterozygosity in human gastric cancers
-
Kaneda, A., et al. 2004. Lysyl oxidase is a tumor suppressor gene inactivated by methylation and loss of heterozygosity in human gastric cancers. Cancer Res. 64:6410-6415.
-
(2004)
Cancer Res
, vol.64
, pp. 6410-6415
-
-
Kaneda, A.1
-
22
-
-
0026426468
-
Lysyl oxidase and rrg mRNA
-
Kenyon, K., et al. 1991. Lysyl oxidase and rrg mRNA. Science 253:802.
-
(1991)
Science
, vol.253
, pp. 802
-
-
Kenyon, K.1
-
23
-
-
0032808432
-
Differentially expressed genes associated with the metastatic phenotype in breast cancer
-
Kirschmann, D. A., E. A. Seftor, D. R. Nieva, E. A. Mariano, and M. J. Hendrix. 1999. Differentially expressed genes associated with the metastatic phenotype in breast cancer. Breast Cancer Res. Treat. 55:127-136.
-
(1999)
Breast Cancer Res. Treat.
, vol.55
, pp. 127-136
-
-
Kirschmann, D.A.1
Seftor, E.A.2
Nieva, D.R.3
Mariano, E.A.4
Hendrix, M.J.5
-
24
-
-
0026718293
-
Isolation of genes specifically expressed in flat revertant cells derived from activated ras-transformed NIH 3T3 cells by treatment with azatyrosine
-
Krzyzosiak, W. J., N. Shindo-Okada, H. Teshima, K. Nakajima, and S. Nishimura. 1992. Isolation of genes specifically expressed in flat revertant cells derived from activated ras-transformed NIH 3T3 cells by treatment with azatyrosine. Proc. Natl. Acad. Sci. U. S. A. 89:4879-4883.
-
(1992)
Proc. Natl. Acad. Sci. U. S. A.
, vol.89
, pp. 4879-4883
-
-
Krzyzosiak, W.J.1
Shindo-Okada, N.2
Teshima, H.3
Nakajima, K.4
Nishimura, S.5
-
25
-
-
0023053020
-
Deficient production of lysyl oxidase in cultures of malignantly transformed human cells
-
Kuivaniemi, H., R. M. Korhonen, A. Vaheri, and K. I. Kivirikko. 1986. Deficient production of lysyl oxidase in cultures of malignantly transformed human cells. FEBS Lett. 195:261-264.
-
(1986)
FEBS Lett
, vol.195
, pp. 261-264
-
-
Kuivaniemi, H.1
Korhonen, R.M.2
Vaheri, A.3
Kivirikko, K.I.4
-
27
-
-
33750437433
-
Lysyl oxidase: an oxidative enzyme and effector of cell function
-
Lucero, H. A., and H. M. Kagan. 2006. Lysyl oxidase: an oxidative enzyme and effector of cell function. Cell. Mol. Life Sci. 63:2304-2316.
-
(2006)
Cell. Mol. Life Sci.
, vol.63
, pp. 2304-2316
-
-
Lucero, H.A.1
Kagan, H.M.2
-
28
-
-
13044281685
-
Target genes of beta-catenin-T cell-factor/lymphoidenhancer-factor signaling in human colorectal carcinomas
-
Mann, B., et al. 1999. Target genes of beta-catenin-T cell-factor/lymphoidenhancer-factor signaling in human colorectal carcinomas. Proc. Natl. Acad. Sci. U. S. A. 96:1603-1608.
-
(1999)
Proc. Natl. Acad. Sci. U. S. A.
, vol.96
, pp. 1603-1608
-
-
Mann, B.1
-
29
-
-
17444419037
-
Wnt signaling in lung cancer
-
Mazieres, J., B. He, L. You, Z. Xu, and D. M. Jablons. 2005. Wnt signaling in lung cancer. Cancer Lett. 222:1-10.
-
(2005)
Cancer Lett
, vol.222
, pp. 1-10
-
-
Mazieres, J.1
He, B.2
You, L.3
Xu, Z.4
Jablons, D.M.5
-
30
-
-
33847075075
-
The tumor suppressor activity of the lysyl oxidase propeptide reverses the invasive phenotype of Her-2/neu-driven breast cancer
-
Min, C., et al. 2007. The tumor suppressor activity of the lysyl oxidase propeptide reverses the invasive phenotype of Her-2/neu-driven breast cancer. Cancer Res. 67:1105-1112.
-
(2007)
Cancer Res
, vol.67
, pp. 1105-1112
-
-
Min, C.1
-
31
-
-
69249094920
-
A loss-of-function polymorphism in the propeptide domain of the LOX gene and breast cancer
-
Min, C., et al. 2009. A loss-of-function polymorphism in the propeptide domain of the LOX gene and breast cancer. Cancer Res. 69:6685-6693.
-
(2009)
Cancer Res
, vol.69
, pp. 6685-6693
-
-
Min, C.1
-
32
-
-
0030474170
-
Evidence for a transcriptional activation function of BRCA1 C-terminal region
-
Monteiro, A. N., A. August, and H. Hanafusa. 1996. Evidence for a transcriptional activation function of BRCA1 C-terminal region. Proc. Natl. Acad. Sci. U. S. A. 93:13595-13599.
-
(1996)
Proc. Natl. Acad. Sci. U. S. A.
, vol.93
, pp. 13595-13599
-
-
Monteiro, A.N.1
August, A.2
Hanafusa, H.3
-
33
-
-
67649662201
-
WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis
-
Nguyen, D. X., et al. 2009. WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis. Cell 138:51-62.
-
(2009)
Cell
, vol.138
, pp. 51-62
-
-
Nguyen, D.X.1
-
34
-
-
39849103401
-
PTPRK negatively regulates transcriptional activity of wild type and mutated oncogenic beta-catenin and affects membrane distribution of beta-catenin/E-cadherin complexes in cancer cells
-
Novellino, L., et al. 2008. PTPRK negatively regulates transcriptional activity of wild type and mutated oncogenic beta-catenin and affects membrane distribution of beta-catenin/E-cadherin complexes in cancer cells. Cell. Signal. 20:872-883.
-
(2008)
Cell. Signal.
, vol.20
, pp. 872-883
-
-
Novellino, L.1
-
35
-
-
4644365708
-
The propeptide domain of lysyl oxidase induces phenotypic reversion of ras-transformed cells
-
Palamakumbura, A. H., et al. 2004. The propeptide domain of lysyl oxidase induces phenotypic reversion of ras-transformed cells. J. Biol. Chem. 279: 40593-40600.
-
(2004)
J. Biol. Chem.
, vol.279
, pp. 40593-40600
-
-
Palamakumbura, A.H.1
-
36
-
-
70349459741
-
Lysyl oxidase propeptide inhibits prostate cancer cell growth by mechanisms that target FGF-2-cell binding and signaling
-
Palamakumbura, A. H., et al. 2009. Lysyl oxidase propeptide inhibits prostate cancer cell growth by mechanisms that target FGF-2-cell binding and signaling. Oncogene 28:3390-3400.
-
(2009)
Oncogene
, vol.28
, pp. 3390-3400
-
-
Palamakumbura, A.H.1
-
37
-
-
0034254406
-
Mammalian LIN-7 PDZ proteins associate with beta-catenin at the cell-cell junctions of epithelia and neurons
-
Perego, C., C. Vanoni, S. Massari, R. Longhi, and G. Pietrini. 2000. Mammalian LIN-7 PDZ proteins associate with beta-catenin at the cell-cell junctions of epithelia and neurons. EMBO J. 19:3978-3989.
-
(2000)
EMBO J
, vol.19
, pp. 3978-3989
-
-
Perego, C.1
Vanoni, C.2
Massari, S.3
Longhi, R.4
Pietrini, G.5
-
38
-
-
0032521198
-
Reduced lysyl oxidase mRNA levels in experimental and human prostate cancer
-
Ren, C., G. Yang, T. L. Timme, T. M. Wheeler, and T. C. Thompson. 1998. Reduced lysyl oxidase mRNA levels in experimental and human prostate cancer. Cancer Res. 58:1285-1290.
-
(1998)
Cancer Res
, vol.58
, pp. 1285-1290
-
-
Ren, C.1
Yang, G.2
Timme, T.L.3
Wheeler, T.M.4
Thompson, T.C.5
-
39
-
-
0023707058
-
Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung
-
Rodenhuis, S., et al. 1988. Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung. Cancer Res. 48:5738-5741.
-
(1988)
Cancer Res
, vol.48
, pp. 5738-5741
-
-
Rodenhuis, S.1
-
40
-
-
0027979801
-
Receptor tyrosine phosphatase R-PTP-kappa mediates homophilic binding
-
Sap, J., Y. P. Jiang, D. Friedlander, M. Grumet, and J. Schlessinger. 1994. Receptor tyrosine phosphatase R-PTP-kappa mediates homophilic binding. Mol. Cell. Biol. 14:1-9.
-
(1994)
Mol. Cell. Biol.
, vol.14
, pp. 1-9
-
-
Sap, J.1
Jiang, Y.P.2
Friedlander, D.3
Grumet, M.4
Schlessinger, J.5
-
41
-
-
79959425815
-
The Ras signaling inhibitor LOX-PP interacts with Hsp70 and c-Raf to reduce Erk activation and transformed phenotype of breast cancer cells
-
Sato, S., et al. 2011. The Ras signaling inhibitor LOX-PP interacts with Hsp70 and c-Raf to reduce Erk activation and transformed phenotype of breast cancer cells. Mol. Cell. Biol. 31:2683-2695.
-
(2011)
Mol. Cell. Biol.
, vol.31
, pp. 2683-2695
-
-
Sato, S.1
-
42
-
-
34447324079
-
Nuclear localization of enhanced green fluorescent protein homomultimers
-
Seibel, N. M., J. Eljouni, M. M. Nalaskowski, and W. Hampe. 2007. Nuclear localization of enhanced green fluorescent protein homomultimers. Anal. Biochem. 368:95-99.
-
(2007)
Anal. Biochem.
, vol.368
, pp. 95-99
-
-
Seibel, N.M.1
Eljouni, J.2
Nalaskowski, M.M.3
Hampe, W.4
-
43
-
-
33845926895
-
A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies
-
Shames, D. S., et al. 2006. A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies. PLoS Med. 3:e486.
-
(2006)
PLoS Med
, vol.3
, pp. 486
-
-
Shames, D.S.1
-
44
-
-
33847323129
-
Epidermalgrowth factor receptor mutations in lung cancer
-
Sharma, S. V., D. W. Bell, J. Settleman, and D. A. Haber. 2007. Epidermalgrowth factor receptor mutations in lung cancer. Nat. Rev. Cancer 7:169-181.
-
(2007)
Nat. Rev. Cancer
, vol.7
, pp. 169-181
-
-
Sharma, S.V.1
Bell, D.W.2
Settleman, J.3
Haber, D.A.4
-
46
-
-
77950391981
-
Lysyl oxidase propeptide inhibits FGF-2-induced signaling and proliferation of osteoblasts
-
Vora, S. R., et al. 2010. Lysyl oxidase propeptide inhibits FGF-2-induced signaling and proliferation of osteoblasts. J. Biol. Chem. 285:7384-7393.
-
(2010)
J. Biol. Chem.
, vol.285
, pp. 7384-7393
-
-
Vora, S.R.1
-
47
-
-
34447120193
-
Repression of BCL2 by the tumor suppressor activity of the lysyl oxidase propeptide inhibits transformed phenotype of lung and pancreatic cancer cells
-
Wu, M., et al. 2007. Repression of BCL2 by the tumor suppressor activity of the lysyl oxidase propeptide inhibits transformed phenotype of lung and pancreatic cancer cells. Cancer Res. 67:6278-6285.
-
(2007)
Cancer Res
, vol.67
, pp. 6278-6285
-
-
Wu, M.1
-
48
-
-
75649109715
-
Receptor type protein tyrosine phosphatase-kappa mediates cross-talk between transforming growth factor-beta and epidermal growth factor receptor signaling pathways in human keratinocytes
-
Xu, Y., et al. 2010. Receptor type protein tyrosine phosphatase-kappa mediates cross-talk between transforming growth factor-beta and epidermal growth factor receptor signaling pathways in human keratinocytes. Mol. Biol. Cell 21:29-35.
-
(2010)
Mol. Biol. Cell
, vol.21
, pp. 29-35
-
-
Xu, Y.1
-
49
-
-
0031579474
-
Molecular cloning and chromosomal localization of a human gene homologous to the murine R-PTP-kappa, a receptor-type protein tyrosine phosphatase
-
Yang, Y., et al. 1997. Molecular cloning and chromosomal localization of a human gene homologous to the murine R-PTP-kappa, a receptor-type protein tyrosine phosphatase. Gene 186:77-82.
-
(1997)
Gene
, vol.186
, pp. 77-82
-
-
Yang, Y.1
-
50
-
-
59449090900
-
The lysyl oxidase pro-peptide attenuates fibronectinmediated activation of focal adhesion kinase and p130Cas in breast cancer cells
-
Zhao, Y., et al. 2009. The lysyl oxidase pro-peptide attenuates fibronectinmediated activation of focal adhesion kinase and p130Cas in breast cancer cells. J. Biol. Chem. 284:1385-1393.
-
(2009)
J. Biol. Chem.
, vol.284
, pp. 1385-1393
-
-
Zhao, Y.1
-
51
-
-
0029005270
-
Homophilic interactions mediated by receptor tyrosine phosphatases mu and kappa, A critical role for the novel extracellular MAM domain
-
Zondag, G. C., et al. 1995. Homophilic interactions mediated by receptor tyrosine phosphatases mu and kappa. A critical role for the novel extracellular MAM domain. J. Biol. Chem. 270:14247-14250.
-
(1995)
J. Biol. Chem.
, vol.270
, pp. 14247-14250
-
-
Zondag, G.C.1
|